Could Viking Therapeutics Next: Will It Challenge Lilly?
The race to own the GLP-1 weight loss market has a new challenger in Viking Therapeutics. This article breaks down wh...
If you're a beginner, knowing which exchanges offer the lowest fees can help you save money. Explore your best options here.
23,160 articlesThe race to own the GLP-1 weight loss market has a new challenger in Viking Therapeutics. This article breaks down wh...
Micron stock has surged on AI tailwinds, but powerful under-the-radar forces could extend the rally. This article exp...
uso’s front month strategy has lagged crude across cycles as roll costs erode returns. This piece analyzes why the dr...
Choosing when to claim Social Security is tough for couples. This guide breaks down the reasons to delay, the tradeof...
As we enter June, investors wonder if summer headwinds are already priced into stocks. This article breaks down prici...
Okta’s COO argues the hardest part of AI adoption is redesigning work itself, not the tech. The stance has broad impl...
Federal prosecutors have opened a formal inquiry into possible insider trading linked to Kalshi bets tied to politica...
As DocuSign navigates a changing digital transaction landscape, the docusign (DOCU) 2027 earnings thesis hinges on re...
With summer on the horizon, energy markets react to travel demand and geopolitics. This guide highlights three energy...
NUKZ is in focus as two pivotal drivers could redefine its trajectory: big-hyperscaler nuclear agreements and the rol...
Cloud giants are expanding, yet the super micro computer stock slid on a capital-raise plan. This article breaks down...
As Uber morphs into a multi-vertical platform, the real question for investors is how quickly it can translate growth...